GleanMark

PROTEGA Trademark

PROTEGA is a USPTO trademark filed by Verici Dx Plc. Status: Pending.

Trademark Facts

MarkPROTEGA
Serial Number99151046
StatusPending
Filing Date2025-04-23
Mark TypeWord
Nice Classes005 (Pharmaceuticals), 010 (Medical Devices), 042 (Software & IT), 044 (Medical Services)
OwnerVerici Dx Plc
Attorney of RecordBrian J. Focarino
Prosecution Events19
Latest EventNOAM on 2026-03-17

Goods & Services

Class 005: Medical diagnostic blood or biopsy testing assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; all of the goods related to the field of organ transplants; Class 010: Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients; all of the goods related to the field of organ transplants; Class 042: Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; all of the services related to the field of organ transplants; Class 044: Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies for predicting and identifying risk of graft rejection in kidney transplant patients; healthcare, namely, medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients

Related